Rotavirus is the most common cause of diarrheal hospitalizations and deaths among children worldwide, killing nearly half a million children under five each year. Two vaccines were recently introduced to the market, but their introduction in countries lags, as does awareness of the true burden of the disease. Since 2004, Sabin, in collaboration with various rotavirus stakeholders, has organized the International Rotavirus Symposium series to bring together scientists, policy makers and other key stakeholders in order to share knowledge and raise the profile of this deadly disease.
The 10th International Rotavirus Symposium was held 19-21 September, 2012 in Bangkok, Thailand. It brought together over 300 interested stakeholders from 47 countries to provide an update on new data and relevant research that will inform public health agendas related to prevention of rotavirus gastroenteritis.
The 9th International Rotavirus Symposium was held 2-3 August 2010 in Johannesburg, South Africa, and brought together over 385 scientists, clinicians, public health professionals, immunization leaders and others from over 65 countries. The event was designed to provide an update on relevant research that will inform public health agendas related to rotavirus gastroenteritis.
A Global Call to Action was issued highlighting the facts associated with rotavirus and the commitment of those in attendance to move the agenda forward.
The 8th International Rotavirus Symposium was held in Istanbul, Turkey on June 3-4, 2008. The meeting was a collaborative effort of the Sabin Vaccine Institute, PATH, the US Centers for Disease Control and Prevention, World Health Organization and the Norwegian Institute of Public Health. The event attracted representatives from over 67 countries who engaged the full range of scientific, social, and economic challenges that must be overcome in order to prevent this major killer of children.
The 7th International Rotavirus Symposium held in Lisbon, Portugal on July 12-13, 2006, brought together 350 participants from the European region to discuss the latest advances of Rotavirus vaccines. The objective of the meeting was to review the substantial progress made in two years toward safe, effective rotavirus vaccines and to address the challenge of ensuring that they get to the world’s poorest children.
The 6th International Rotavirus Symposium brought together 420 participants from the Latin American region to discuss the latest advances of Rotavirus vaccines. At the time of the conference, held in Mexico City on July 7-9, 2004, two rotavirus vaccines had recently become available.